Senate Bill 422 introduces new requirements for health insurance coverage concerning advanced or metastatic cancer in Montana. The bill prohibits insurers from mandating that patients try alternative prescription drugs before covering FDA-approved treatments, provided that the prescribing adheres to national comprehensive cancer network guidelines. It also clarifies the definition of "advanced or metastatic cancer" to include cases where cancer has spread beyond its original site or is terminal. Furthermore, the bill amends existing laws to ensure that treatment for advanced or metastatic cancer is explicitly included in insurance coverage provisions.

The bill makes specific amendments to the Montana Code Annotated (MCA), particularly in Section 4, which addresses the application of the insurance code to self-funded multiple employer welfare arrangements. This amendment clarifies that these arrangements are subject to certain provisions of Title 33 while excluding others that do not apply to self-funded arrangements with an unrevoked certificate of authority. Additionally, Section 5 states that the new provisions will be codified as part of Title 33, chapter 22, part 1, thereby enhancing protections and access to necessary treatments for patients diagnosed with advanced or metastatic cancer.

Statutes affected:
LC Text: 2-18-704, 33-31-111, 33-35-306
SB0422_1(1): 2-18-704, 33-31-111, 33-35-306
SB0422_1(2): 2-18-704, 33-31-111, 33-35-306
SB0422_1(3): 2-18-704, 33-31-111, 33-35-306
SB0422_1(4): 2-18-704, 33-31-111, 33-35-306
SB0422_1: 2-18-704, 33-31-111, 33-35-306
SB0422_2(1): 2-18-704, 33-31-111, 33-35-306
SB0422_2(10): 2-18-704, 33-31-111, 33-35-306
SB0422_2(11): 2-18-704, 33-31-111, 33-35-306
SB0422_2(12): 2-18-704, 33-31-111, 33-35-306
SB0422_2(13): 2-18-704, 33-31-111, 33-35-306
SB0422_2(2): 2-18-704, 33-31-111, 33-35-306
SB0422_2(3): 2-18-704, 33-31-111, 33-35-306
SB0422_2(4): 2-18-704, 33-31-111, 33-35-306
SB0422_2(5): 2-18-704, 33-31-111, 33-35-306
SB0422_2(6): 2-18-704, 33-31-111, 33-35-306
SB0422_2(7): 2-18-704, 33-31-111, 33-35-306
SB0422_2(8): 2-18-704, 33-31-111, 33-35-306
SB0422_2(9): 2-18-704, 33-31-111, 33-35-306
SB0422_2: 2-18-704, 33-31-111, 33-35-306
SB0422_3(1): 2-18-704, 33-31-111, 33-35-306
SB0422_3(2): 2-18-704, 33-31-111, 33-35-306
SB0422_3(3): 2-18-704, 33-31-111, 33-35-306
SB0422_3(4): 2-18-704, 33-31-111, 33-35-306
SB0422_3(5): 2-18-704, 33-31-111, 33-35-306
SB0422_3(6): 2-18-704, 33-31-111, 33-35-306
SB0422_3: 2-18-704, 33-31-111, 33-35-306
SB0422_X(1): 2-18-704, 33-31-111, 33-35-306
SB0422_X(2): 2-18-704, 33-31-111, 33-35-306
SB0422_X(3): 2-18-704, 33-31-111, 33-35-306
SB0422_X(4): 2-18-704, 33-31-111, 33-35-306
SB0422_X(5): 2-18-704, 33-31-111, 33-35-306
SB0422_X(6): 2-18-704, 33-31-111, 33-35-306
SB0422_X(7): 2-18-704, 33-31-111, 33-35-306
SB0422_X(8): 2-18-704, 33-31-111, 33-35-306
SB0422_X(9): 2-18-704, 33-31-111, 33-35-306
SB0422_X: 2-18-704, 33-31-111, 33-35-306